These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 17348010)

  • 41. Lytic Inactivation of Human Immunodeficiency Virus by Dual Engagement of gp120 and gp41 Domains in the Virus Env Protein Trimer.
    Parajuli B; Acharya K; Yu R; Ngo B; Rashad AA; Abrams CF; Chaiken IM
    Biochemistry; 2016 Nov; 55(44):6100-6114. PubMed ID: 27731975
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structural basis for the interaction between focal adhesion kinase and CD4.
    Garron ML; Arthos J; Guichou JF; McNally J; Cicala C; Arold ST
    J Mol Biol; 2008 Feb; 375(5):1320-8. PubMed ID: 18078954
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression and purification of glutathione S-transferase-tagged HIV-1 gp120: no evidence of an interaction with CD26.
    Wang YH; Davies AH; Jones IM
    Virology; 1995 Apr; 208(1):142-6. PubMed ID: 11831694
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Domain-swapped structure of a mutant of cyanovirin-N.
    Botos I; Mori T; Cartner LK; Boyd MR; Wlodawer A
    Biochem Biophys Res Commun; 2002 May; 294(1):184-90. PubMed ID: 12054761
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Probing the HIV gp120 envelope glycoprotein conformation by NMR.
    Celigoy J; Ramirez B; Tao L; Rong L; Yan L; Feng YR; Quinnan GV; Broder CC; Caffrey M
    J Biol Chem; 2011 Jul; 286(27):23975-81. PubMed ID: 21592971
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Computational study of the dynamics of mannose disaccharides free in solution and bound to the potent anti-HIV virucidal protein cyanovirin.
    Margulis CJ
    J Phys Chem B; 2005 Mar; 109(8):3639-47. PubMed ID: 16851402
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Moesin is required for HIV-1-induced CD4-CXCR4 interaction, F-actin redistribution, membrane fusion and viral infection in lymphocytes.
    Barrero-Villar M; Cabrero JR; Gordón-Alonso M; Barroso-González J; Alvarez-Losada S; Muñoz-Fernández MA; Sánchez-Madrid F; Valenzuela-Fernández A
    J Cell Sci; 2009 Jan; 122(Pt 1):103-13. PubMed ID: 19066282
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Binding kinetics, uptake and intracellular accumulation of F105, an anti-gp120 human IgG1kappa monoclonal antibody, in HIV-1 infected cells.
    Clayton R; Ohagen A; Goethals O; Smets A; Van Loock M; Michiels L; Kennedy-Johnston E; Cunningham M; Jiang H; Bola S; Gutshall L; Gunn G; Del Vecchio A; Sarisky R; Hallenberger S; Hertogs K
    J Virol Methods; 2007 Jan; 139(1):17-23. PubMed ID: 17034868
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Peptide ligands to human immunodeficiency virus type 1 gp120 identified from phage display libraries.
    Ferrer M; Harrison SC
    J Virol; 1999 Jul; 73(7):5795-802. PubMed ID: 10364331
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Proteins that bind high-mannose sugars of the HIV envelope.
    Botos I; Wlodawer A
    Prog Biophys Mol Biol; 2005 Jun; 88(2):233-82. PubMed ID: 15572157
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression, purification, and characterization of recombinant cyanovirin-N for vaginal anti-HIV microbicide development.
    Colleluori DM; Tien D; Kang F; Pagliei T; Kuss R; McCormick T; Watson K; McFadden K; Chaiken I; Buckheit RW; Romano JW
    Protein Expr Purif; 2005 Feb; 39(2):229-36. PubMed ID: 15642474
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of putative, stable binding regions through flexibility analysis of HIV-1 gp120.
    Tan H; Rader AJ
    Proteins; 2009 Mar; 74(4):881-94. PubMed ID: 18704932
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multivalent interactions with gp120 are required for the anti-HIV activity of Cyanovirin.
    Liu Y; Carroll JR; Holt LA; McMahon J; Giomarelli B; Ghirlanda G
    Biopolymers; 2009; 92(3):194-200. PubMed ID: 19235857
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic engineering, expression, and activity of a chimeric monoclonal antibody-avidin fusion protein for receptor-mediated delivery of biotinylated drugs in humans.
    Boado RJ; Zhang Y; Zhang Y; Xia CF; Wang Y; Pardridge WM
    Bioconjug Chem; 2008 Mar; 19(3):731-9. PubMed ID: 18278853
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The anti-HIV cyanovirin-N domain is evolutionarily conserved and occurs as a protein module in eukaryotes.
    Percudani R; Montanini B; Ottonello S
    Proteins; 2005 Sep; 60(4):670-8. PubMed ID: 16003744
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relative concordance of human immunodeficiency virus oligomeric and monomeric envelope in CCR5 coreceptor usage.
    Teeravechyan S; Suphaphiphat P; Essex M; Lee TH
    Virology; 2008 Jan; 370(2):443-50. PubMed ID: 17936869
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD4-BFFI: a novel, bifunctional HIV-1 entry inhibitor with high and broad antiviral potency.
    Jekle A; Chow E; Kopetzki E; Ji C; Yan MJ; Nguyen R; Sankuratri S; Cammack N; Heilek G
    Antiviral Res; 2009 Sep; 83(3):257-66. PubMed ID: 19559732
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HIV-1 Env gp120 structural determinants for peptide triazole dual receptor site antagonism.
    Tuzer F; Madani N; Kamanna K; Zentner I; LaLonde J; Holmes A; Upton E; Rajagopal S; McFadden K; Contarino M; Sodroski J; Chaiken I
    Proteins; 2013 Feb; 81(2):271-90. PubMed ID: 23011758
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Selective interactions of the human immunodeficiency virus-inactivating protein cyanovirin-N with high-mannose oligosaccharides on gp120 and other glycoproteins.
    Shenoy SR; O'Keefe BR; Bolmstedt AJ; Cartner LK; Boyd MR
    J Pharmacol Exp Ther; 2001 May; 297(2):704-10. PubMed ID: 11303061
    [TBL] [Abstract][Full Text] [Related]  

  • 60. C-type lectin Mermaid inhibits dendritic cell mediated HIV-1 transmission to CD4+ T cells.
    Nabatov AA; de Jong MA; de Witte L; Bulgheresi S; Geijtenbeek TB
    Virology; 2008 Sep; 378(2):323-8. PubMed ID: 18597806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.